ONESOURCE — Onesource Specialty Pharma Cashflow Statement
0.000.00%
- IN₹182.12bn
- IN₹187.79bn
- IN₹1.72bn
Annual cashflow statement for Onesource Specialty Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | ARS | ARS |
Standards: | IAS | IAS |
Status: | Final | Final |
Net Income/Starting Line | -4,156 | -3,657 |
Depreciation | ||
Non-Cash Items | 1,061 | 1,672 |
Discontinued Operations | ||
Unusual Items | ||
Other Non-Cash Items | ||
Changes in Working Capital | 326 | -41.3 |
Change in Accounts Receivable | ||
Change in Inventories | ||
Change in Other Assets | ||
Change in Accounts Payable | ||
Change in Other Liabilities | ||
Other Operating Cash Flow | ||
Cash from Operating Activities | -1,628 | -1,072 |
Capital Expenditures | -440 | -638 |
Purchase of Fixed Assets | ||
Other Investing Cash Flow Items | -238 | 5,743 |
Sale of Fixed Assets | ||
Sale/Maturity of Investment | ||
Purchase of Investments | ||
Change in Net Intangibles | ||
Other Investing Cash Flow | ||
Cash from Investing Activities | -678 | 5,105 |
Financing Cash Flow Items | -1,053 | -1,033 |
Other Financing Cash Flow | ||
Net Issuance / Retirement of Stock | ||
Net Issuance / Retirement of Debt | ||
Cash from Financing Activities | 1,183 | -3,905 |
Beginning Cash Balance | ||
Ending Cash Balance | ||
Net Change in Cash | -1,123 | 128 |